The FDA has approved Spravato nasal spray to treat major depressive disorder

Date: Mar 05 2019

Spravato nasal spray, also known as esketamine, can now be used to treat depression in adults with treatment-resistant depression.

     

 

 

http://rssfeeds.usatoday.com/~/599225614/0/usatodaycommoney-topstories~The-FDA-has-approved-Spravato-nasal-spray-to-treat-major-depressive-disorder/

«

»